Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Strong Performer, Under Radar
976.1500 14.35 (1.49%)
NSE Jul 14, 2025 10:06 AM
Volume: 288.0K
 

logo
Natco Pharma Ltd.
11 Aug 2022
976.15
1.49%
buy
by ICICI Securities Limited
Target: 818
ICICI Securities Limited
Natco Pharma’s (Natco) Q1FY23 performance was ahead of our estimates led by ramp-up in Revlimid.
 
Number of FII/FPI investors decreased from 435 to 385 in Mar 2025 qtr
More from Natco Pharma Ltd.
Recommended
Market opens flat, Avenue Supermarts' Q1 net profit misses Forecaster estimates by 10.1%
Trendlyne Marketwatch | 14 Jul 2025, 10:02AM
Five Interesting Stocks Today - July 11, 2025
The Baseline | 11 Jul 2025
Earnings Call Transcript - Q4FY20 for Natco Pharma
| 18 Jun 2020